{
    "code": "10000612",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000612",
    "time": "2020-02-26 01:39:12",
    "許可證字號": "衛署菌疫輸字第000612號",
    "註銷狀態": "已註銷",
    "註銷日期": "90\/01\/03",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "94\/08\/31",
    "發證日期": "89\/08\/31",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000061204",
    "中文品名": "基因工程第八凝血因子注射劑〝貝靈〞",
    "英文品名": "HELIXATE, ANTIHEMOPHILIC FACTOR (RECOMBINANT)",
    "適應症": "治療Ａ型血友病。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶附溶液",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "FACTOR VIII",
    "限制項目": "02輸　入",
    "申請商名稱": "1426201100  臺灣拜耳股份有限公司",
    "申請商地址": "台北巿松江路２３７號９Ｆ",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0301000  BAYER CORPORATION PHARMACEUTICAL DIVISION",
            "製造廠廠址": "8368 U.S. 70 WEST CLAYTON NC 27520 U.S.A.800 DWIGHT WAY,P.O.BOX 1986,BERKELEY CA94701-1986 U.S.A.",
            "製造廠公司地址": "800 DWIGHT WAY,P.O.BOX 1986,BERKELEY CA94701-1986 U.S.A.",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004003300",
            "成分名稱": "FACTOR VIII",
            "含量描述": "NLE 80",
            "含量": "",
            "單位": "IU (I"
        }
    ]
}